Supplementary analysis produced to support Cabinet’s decision to introduce the Therapeutic Products Bill to Parliament in 2022.
This supplementary RIS examines options to address issues that were not explored in the previous RIS, specifically the inclusion of a civil pecuniary penalty regime and extending civil and criminal liability to the Crown.
